What are the major opportunities in the Next-Generation Antibody Therapeutics market? What are the strategies for the Next-Generation Antibody Therapeutics market?

For detailed insights on the major opportunities and strategies in the Next-Generation Antibody Therapeutics market, Read More

How does the Next-Generation Antibody Therapeutics market relate to the overall economy and other similar markets?

For detailed insights on Next-Generation Antibody Therapeutics's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Next-Generation Antibody Therapeutics market growth? SWOT analysis of the Next-Generation Antibody Therapeutics market.

For detailed insights on the key dynamics influencing the Next-Generation Antibody Therapeutics market growth and SWOT analysis of the Next-Generation Antibody Therapeutics industry, Read More

Next-Generation Antibody Therapeutics Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : January 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Next-Generation Antibody Therapeutics Market Report 2026

Name: Next-Generation Antibody Therapeutics Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Types Of Antibodies (Monoclonal Antibodies, Polyclonal Antibodies, Bispecific Antibodies, Antibody-Drug Conjugates, Other Types), By Therapeutic Area (Oncology, Autoimmune Diseases, Infectious Diseases, Neurodegenerative Disorders, Other Therapeutic Areas), By End-User (Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Next-Generation Antibody Therapeutics Market Overview

• Next-Generation Antibody Therapeutics market size has reached to $7.56 billion in 2025

• Expected to grow to $12.63 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%

• Growth Driver: Next-Generation Antibody Therapeutics Is A Vital Solution In Addressing The Surge Of Chronic Diseases

• Market Trend: Revolutionizing Antibody Therapeutics By Exploring Cutting-Edge Technologies And Breakthroughs In Next-Generation Solutions

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Next-Generation Antibody Therapeutics Market?

Next-generation antibody therapeutics are advanced antibody-based drugs in structure, functionality, and therapeutic potential beyond traditional monoclonal antibodies. It treats several severe medical problems, including cancer, infectious infections, and immunological disorders.

The main types of antibodies in next-generation antibody therapeutics are monoclonal antibodies, polyclonal antibodies, biospecific antibodies, antibody-drug conjugates, and others. Monoclonal antibodies refer to a particular kind of laboratory-produced protein that can bind to certain bodily targets, such as antigens on the surface of cancer cells. The various therapeutic areas are oncology, autoimmune diseases, infectious diseases, neurodegenerative disorders, and others used in hospitals and clinics, research institutes, pharmaceutical and biotechnology companies, and others.

Next-Generation Antibody Therapeutics Market Global Report 2026 Market Report bar graph

What Is The Next-Generation Antibody Therapeutics Market Size and Share 2026?

The next-generation antibody therapeutics market size has grown rapidly in recent years. It will grow from $7.56 billion in 2025 to $8.35 billion in 2026 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to growth in monoclonal antibody approvals, increasing cancer prevalence, expansion of biologics manufacturing capacity, rising investment in pharmaceutical r&d, improved regulatory pathways for biologics.

What Is The Next-Generation Antibody Therapeutics Market Growth Forecast?

The next-generation antibody therapeutics market size is expected to see rapid growth in the next few years. It will grow to $12.63 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to advancement in antibody engineering technologies, rising demand for targeted therapies, increasing incidence of chronic and autoimmune diseases, expansion of clinical trials in emerging markets, growing partnerships between biotech and pharma companies. Major trends in the forecast period include expansion of bispecific and multispecific antibody platforms, growing adoption of antibody-drug conjugates in oncology, increased focus on high-affinity and long-acting antibodies, rising clinical pipeline for rare and orphan diseases, shift toward personalized antibody-based therapies.

Book your 30 minutes free consultation with our research experts

Global Next-Generation Antibody Therapeutics Market Segmentation

1) By Types Of Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Bispecific Antibodies, Antibody-Drug Conjugates, Other Types

2) By Therapeutic Area: Oncology, Autoimmune Diseases, Infectious Diseases, Neurodegenerative Disorders, Other Therapeutic Areas

3) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By Monoclonal Antibodies: IgG Monoclonal Antibodies, IgM Monoclonal Antibodies

2) By Polyclonal Antibodies: Serum-Derived Polyclonal Antibodies, Hybridoma-Derived Polyclonal Antibodies

3) By Bispecific Antibodies: Dual-Targeting Antibodies, Single-Chain Variable Fragment (scFv) Antibodies

4) By Antibody-Drug Conjugates (ADCs): Targeted ADCs, Payload Types

5) By Other Types: Nanobodies, Engineered Antibodies

What Is The Driver Of The Next-Generation Antibody Therapeutics Market?

The increasing prevalence of chronic diseases is expected to propel the growth of the next-generation antibody therapeutics market going forward. Chronic diseases are problems that last a year or longer, necessitating continuing medical care, restricting everyday activities, or both. Next-generation antibody therapeutics have a therapeutic function for individuals with chronic illnesses that deliver more focused care, which would benefit patients’ outcomes. For instance, in January 2023, according to the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, it was projected that by the year 2050, the number of individuals aged 50 years and older who have at least one chronic illness will surge by 99.5%, rising to 142.66 million. Therefore, the increasing prevalence of chronic diseases is driving the growth of the next-generation antibody therapeutics industry.

Key Players In The Global Next-Generation Antibody Therapeutics Market

Major companies operating in the next-generation antibody therapeutics market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, AstraZeneca plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Genentech Inc., Kyowa Hakko Kirin Co. Ltd., Seagen Inc., Seattle Genetics Inc., Xencor Inc., ImmunoGen Inc., Genmab A/S, Zymeworks Inc., NBE-Therapeutics AG, Daiichi Sankyo Company Limited, Merck & Co Inc., Novartis AG, AbCellera Biologics Inc., Sotio Biotech, F-Star Therapeutics Ltd., ADC Therapeutics SA, Harbour BioMed

Global Next-Generation Antibody Therapeutics Market Trends and Insights

Major companies operating in the next-generation antibody therapeutics market are focused on developing technological advancements such as proprietary Molecular Indexing of Proteins by Self-Assembly (MIPSA) technology to enhance protein identification and characterization, leading to more targeted and effective treatments. As a result, these advancements aim to improve therapeutic profiles, reduce costs, and address complex diseases with greater precision. Molecular Indexing of Proteins by Self-Assembly (MIPSA) is a technology that organizes protein molecules into structured assemblies for enhanced analysis and quantification. It improves sensitivity and accuracy in protein detection, useful in research and diagnostics. For instance, in January 2024, Infinity Bio, Inc., a US-based biotechnology company, launched a next-generation antibody profiling platform, that utilizes MIPSA technology for high-throughput, cost-effective analysis of immune responses, aiming to enhance disease understanding and personalize treatment strategies.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Next-Generation Antibody Therapeutics Market?

In February 2024, AbbVie Inc., a US-based pharmaceutical company, acquired ImmunoGen, Inc. for approximately US$10.1 billion. Through this acquisition, AbbVie aims to enhance its next-generation antibody therapeutic capabilities by integrating ImmunoGen’s folate receptor-alpha–targeted antibody-drug conjugate, ELAHERE approved for platinum-resistant ovarian cancer and by expanding its pipeline of antibody-drug conjugates across solid tumors and hematologic malignancies. ImmunoGen, Inc. is a US-based biotechnology company specializing in the development of innovative antibody-drug conjugate platforms for oncology.

Regional Outlook

North America was the largest region in the next-generation antibody therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Next-Generation Antibody Therapeutics Market?

The next-generation antibody therapeutics market consists of revenues earned by entities by providing services such as antibody engineering, antibody manufacturing, and regulatory support. The market value includes the value of related goods sold by the service provider or included within the service offering. The next-generation antibody therapeutics market also includes sales of immune checkpoint inhibitors, antibody-targeted nanoparticles, and antibody-mimetic proteins. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Next-Generation Antibody Therapeutics Market Report 2026?

The next-generation antibody therapeutics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the next-generation antibody therapeutics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Next-Generation Antibody Therapeutics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$8.35 billion
Revenue Forecast In 2035	$12.63 billion
Growth Rate	CAGR of 10.4% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Types Of Antibodies, Therapeutic Area, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc., F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, AstraZeneca plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Genentech Inc., Kyowa Hakko Kirin Co. Ltd., Seagen Inc., Seattle Genetics Inc., Xencor Inc., ImmunoGen Inc., Genmab A/S, Zymeworks Inc., NBE-Therapeutics AG, Daiichi Sankyo Company Limited, Merck & Co Inc., Novartis AG, AbCellera Biologics Inc., Sotio Biotech, F-Star Therapeutics Ltd., ADC Therapeutics SA, Harbour BioMed
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Next-Generation Antibody Therapeutics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Next-Generation Antibody Therapeutics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Next-Generation Antibody Therapeutics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Next-Generation Antibody Therapeutics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Expansion Of Bispecific And Multispecific Antibody Platforms

4.2.2 Growing Adoption Of Antibody-Drug Conjugates In Oncology

4.2.3 Increased Focus On High-Affinity And Long-Acting Antibodies

4.2.4 Rising Clinical Pipeline For Rare And Orphan Diseases

4.2.5 Shift Toward Personalized Antibody-Based Therapies

5. Next-Generation Antibody Therapeutics Market Analysis Of End Use Industries

5.1 Hospitals And Clinics

5.2 Pharmaceutical And Biotechnology Companies

5.3 Research Institutes

5.4 Contract Research Organizations

5.5 Specialty Cancer Treatment Centers

6. Next-Generation Antibody Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Next-Generation Antibody Therapeutics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Next-Generation Antibody Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Next-Generation Antibody Therapeutics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Next-Generation Antibody Therapeutics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Next-Generation Antibody Therapeutics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Next-Generation Antibody Therapeutics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Next-Generation Antibody Therapeutics Market Segmentation

9.1. Global Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Monoclonal Antibodies, Polyclonal Antibodies, Bispecific Antibodies, Antibody-Drug Conjugates, Other Types

9.2. Global Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oncology, Autoimmune Diseases, Infectious Diseases, Neurodegenerative Disorders, Other Therapeutic Areas

9.3. Global Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

9.4. Global Next-Generation Antibody Therapeutics Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

IgG Monoclonal Antibodies, IgM Monoclonal Antibodies

9.5. Global Next-Generation Antibody Therapeutics Market, Sub-Segmentation Of Polyclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Serum-Derived Polyclonal Antibodies, Hybridoma-Derived Polyclonal Antibodies

9.6. Global Next-Generation Antibody Therapeutics Market, Sub-Segmentation Of Bispecific Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Dual-Targeting Antibodies, Single-Chain Variable Fragment (scFv) Antibodies

9.7. Global Next-Generation Antibody Therapeutics Market, Sub-Segmentation Of Antibody-Drug Conjugates (ADCs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Targeted ADCs, Payload Types

9.8. Global Next-Generation Antibody Therapeutics Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Nanobodies, Engineered Antibodies

10. Next-Generation Antibody Therapeutics Market Regional And Country Analysis

10.1. Global Next-Generation Antibody Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Next-Generation Antibody Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Next-Generation Antibody Therapeutics Market

11.1. Asia-Pacific Next-Generation Antibody Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Next-Generation Antibody Therapeutics Market

12.1. China Next-Generation Antibody Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Next-Generation Antibody Therapeutics Market

13.1. India Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Next-Generation Antibody Therapeutics Market

14.1. Japan Next-Generation Antibody Therapeutics Market Overview

14.2. Japan Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Next-Generation Antibody Therapeutics Market

15.1. Australia Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Next-Generation Antibody Therapeutics Market

16.1. Indonesia Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Next-Generation Antibody Therapeutics Market

17.1. South Korea Next-Generation Antibody Therapeutics Market Overview

17.2. South Korea Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Next-Generation Antibody Therapeutics Market

18.1. Taiwan Next-Generation Antibody Therapeutics Market Overview

18.2. Taiwan Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Next-Generation Antibody Therapeutics Market

19.1. South East Asia Next-Generation Antibody Therapeutics Market Overview

19.2. South East Asia Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Next-Generation Antibody Therapeutics Market

20.1. Western Europe Next-Generation Antibody Therapeutics Market Overview

20.2. Western Europe Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Next-Generation Antibody Therapeutics Market

21.1. UK Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Next-Generation Antibody Therapeutics Market

22.1. Germany Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Next-Generation Antibody Therapeutics Market

23.1. France Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Next-Generation Antibody Therapeutics Market

24.1. Italy Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Next-Generation Antibody Therapeutics Market

25.1. Spain Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Next-Generation Antibody Therapeutics Market

26.1. Eastern Europe Next-Generation Antibody Therapeutics Market Overview

26.2. Eastern Europe Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Next-Generation Antibody Therapeutics Market

27.1. Russia Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Next-Generation Antibody Therapeutics Market

28.1. North America Next-Generation Antibody Therapeutics Market Overview

28.2. North America Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Next-Generation Antibody Therapeutics Market

29.1. USA Next-Generation Antibody Therapeutics Market Overview

29.2. USA Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Next-Generation Antibody Therapeutics Market

30.1. Canada Next-Generation Antibody Therapeutics Market Overview

30.2. Canada Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Next-Generation Antibody Therapeutics Market

31.1. South America Next-Generation Antibody Therapeutics Market Overview

31.2. South America Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Next-Generation Antibody Therapeutics Market

32.1. Brazil Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Next-Generation Antibody Therapeutics Market

33.1. Middle East Next-Generation Antibody Therapeutics Market Overview

33.2. Middle East Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Next-Generation Antibody Therapeutics Market

34.1. Africa Next-Generation Antibody Therapeutics Market Overview

34.2. Africa Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Next-Generation Antibody Therapeutics Market Regulatory and Investment Landscape

36. Next-Generation Antibody Therapeutics Market Competitive Landscape And Company Profiles

36.1. Next-Generation Antibody Therapeutics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Next-Generation Antibody Therapeutics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Next-Generation Antibody Therapeutics Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

36.3.4. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

36.3.5. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

37. Next-Generation Antibody Therapeutics Market Other Major And Innovative Companies

Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Genentech Inc., Kyowa Hakko Kirin Co. Ltd., Seagen Inc., Seattle Genetics Inc., Xencor Inc., ImmunoGen Inc., Genmab A/S, Zymeworks Inc., NBE-Therapeutics AG, Daiichi Sankyo Company Limited

38. Global Next-Generation Antibody Therapeutics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Next-Generation Antibody Therapeutics Market

40. Next-Generation Antibody Therapeutics Market High Potential Countries, Segments and Strategies

40.1 Next-Generation Antibody Therapeutics Market In 2030 - Countries Offering Most New Opportunities

40.2 Next-Generation Antibody Therapeutics Market In 2030 - Segments Offering Most New Opportunities

40.3 Next-Generation Antibody Therapeutics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Next-Generation Antibody Therapeutics Market, Overview Of Key Products - Product Examples

Table 2: Global Next-Generation Antibody Therapeutics Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Next-Generation Antibody Therapeutics Market, Supply Chain Analysis

Table 4: Global Next-Generation Antibody Therapeutics Market, Major Raw Material Providers

Table 5: Global Next-Generation Antibody Therapeutics Market, Major Resource Providers

Table 6: Global Next-Generation Antibody Therapeutics Market, Major Manufacturers (Suppliers)

Table 7: Global Next-Generation Antibody Therapeutics Market, Major Distributors And Channel Partners

Table 8: Global Next-Generation Antibody Therapeutics Market, Key Technologies & Future Trends

Table 9: Global Next-Generation Antibody Therapeutics Market, Major Trends

Table 10: Global Next-Generation Antibody Therapeutics Market, Major End Users

Table 11: Global Next-Generation Antibody Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Next-Generation Antibody Therapeutics Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Next-Generation Antibody Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Next-Generation Antibody Therapeutics Market - TAM, US$ Billion, 2025

Table 15: Global Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Next-Generation Antibody Therapeutics Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Next-Generation Antibody Therapeutics Market, Sub-Segmentation Of Polyclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Next-Generation Antibody Therapeutics Market, Sub-Segmentation Of Bispecific Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Next-Generation Antibody Therapeutics Market, Sub-Segmentation Of Antibody-Drug Conjugates (ADCs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Next-Generation Antibody Therapeutics Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Next-Generation Antibody Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Next-Generation Antibody Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Global Next-Generation Antibody Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 98: Global Next-Generation Antibody Therapeutics Market - Company Scoring Matrix

Table 99: Pfizer Inc. Financial Performance

Table 100: F. Hoffmann-La Roche Ltd. Financial Performance

Table 101: Bristol-Myers Squibb Company Financial Performance

Table 102: AstraZeneca plc Financial Performance

Table 103: GlaxoSmithKline plc Financial Performance

Table 104: Global Next-Generation Antibody Therapeutics Market, Competitive Benchmarking (In USD Billions)

Table 105: Global Next-Generation Antibody Therapeutics Market, Competitive Dashboard

Table 106: Global Next-Generation Antibody Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 107: Global, Next-Generation Antibody Therapeutics Market Size Gain ($ Billion), Segmentation By Types Of Antibodies, 2025 – 2030

Table 108: Global, Next-Generation Antibody Therapeutics Market Size Gain ($ Billion), Segmentation By Therapeutic Area, 2025 – 2030

Table 109: Global, Next-Generation Antibody Therapeutics Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

List Of Figures

Figure 1: Global Next-Generation Antibody Therapeutics Market, Overview Of Key Products - Product Examples

Figure 2: Global Next-Generation Antibody Therapeutics Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Next-Generation Antibody Therapeutics Market, Supply Chain Analysis

Figure 4: Global Next-Generation Antibody Therapeutics Market, Major Raw Material Providers

Figure 5: Global Next-Generation Antibody Therapeutics Market, Major Resource Providers

Figure 6: Global Next-Generation Antibody Therapeutics Market, Major Manufacturers (Suppliers)

Figure 7: Global Next-Generation Antibody Therapeutics Market, Major Distributors And Channel Partners

Figure 8: Global Next-Generation Antibody Therapeutics Market, Key Technologies & Future Trends

Figure 9: Global Next-Generation Antibody Therapeutics Market, Major Trends

Figure 10: Global Next-Generation Antibody Therapeutics Market, Major End Users

Figure 11: Global Next-Generation Antibody Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Next-Generation Antibody Therapeutics Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Next-Generation Antibody Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Next-Generation Antibody Therapeutics Market - TAM, US$ Billion, 2025

Figure 15: Global Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Next-Generation Antibody Therapeutics Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Next-Generation Antibody Therapeutics Market, Sub-Segmentation Of Polyclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Next-Generation Antibody Therapeutics Market, Sub-Segmentation Of Bispecific Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Next-Generation Antibody Therapeutics Market, Sub-Segmentation Of Antibody-Drug Conjugates (ADCs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Next-Generation Antibody Therapeutics Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Next-Generation Antibody Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Next-Generation Antibody Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Next-Generation Antibody Therapeutics Market, Segmentation By Types Of Antibodies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Next-Generation Antibody Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Next-Generation Antibody Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Global Next-Generation Antibody Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 98: Global Next-Generation Antibody Therapeutics Market - Company Scoring Matrix

Figure 99: Pfizer Inc. Financial Performance

Figure 100: F. Hoffmann-La Roche Ltd. Financial Performance

Figure 101: Bristol-Myers Squibb Company Financial Performance

Figure 102: AstraZeneca plc Financial Performance

Figure 103: GlaxoSmithKline plc Financial Performance

Figure 104: Global Next-Generation Antibody Therapeutics Market, Competitive Benchmarking (In USD Billions)

Figure 105: Global Next-Generation Antibody Therapeutics Market, Competitive Dashboard

Figure 106: Global Next-Generation Antibody Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 107: Global, Next-Generation Antibody Therapeutics Market Size Gain ($ Billion), Segmentation By Types Of Antibodies, 2025 – 2030

Figure 108: Global, Next-Generation Antibody Therapeutics Market Size Gain ($ Billion), Segmentation By Therapeutic Area, 2025 – 2030

Figure 109: Global, Next-Generation Antibody Therapeutics Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

Coxsackievirus Infections Treatment Market Outlook 2025–2034: Identifying Growth Drivers, Technology Trends, and Policy Impact

Cranial Fixation System Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

Crow's Feet Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead

Cutaneous Squamous Cell Carcinoma (cSCC) Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Antibody Discovery Market Report 2026 - Global Outlook – By Methods (Phage Display, Hybridoma, Other Methods), By Antibody Type (Humanized Antibody, Human Antibody, Chimeric Antibody, Murine Antibody), By End Users (Phar...

Antibody Drug Conjugates Market Report 2026 - Global Outlook – By Type (Monoclonal Antibodies, Linker, Drug/Toxin, Other Types ), By Product Brand (Adcertis, Kadcyla, Other Product Brands), By Technology (Immunogen Techn...

Monoclonal Antibodies (MAs) Market Report 2026 - Global Outlook – By Source (Murine, Chimeric, Humanized, Human ), By Application (Anti-Cancer, Immunological, Anti-Infective Monoclonal Antibodies (MAs), Neuropharmacologi...

Research Antibodies and Reagents Market Report 2026 - Global Outlook – By Technology (Western Blot, Immunofluorescence, Immunohistochemistry, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (Elisa), Others), By Applica...

Monoclonal Antibodies (MAs) Market Report 2026 - Global Outlook – By Source (Murine, Chimeric, Humanized, Human ), By Application (Anti-Cancer, Immunological, Anti-Infective Monoclonal Antibodies (MAs), Neuropharmacologi...

Therapeutic BCG Vaccines Market Report 2026 - Global Outlook – By Type (Therapy BCG, Other Types), By Demographics (Pediatrics, Adults), By End Use (Hospitals, Clinics, Other End Users) - Market Size, Trends, And Global ...

Polyclonal Antibodies Market Report 2026 - Global Outlook – By Product Type (Primary Antibody, Secondary Antibody), By Source (Rabbits, Goats, Sheep, Other Sources), By Application (Research, Diagnostics, Therapy), By En...

Frequently Asked Questions

What is the projected market size of the Next-Generation Antibody Therapeutics Market Report 2026 market by 2030?

The Next-Generation Antibody Therapeutics Market Report 2026 market was valued at $7.56 billion in 2025, increased to $8.35 billion in 2026, and is projected to reach $12.63 billion by 2030. request a sample here

What is the expected CAGR for the Next-Generation Antibody Therapeutics Market Report 2026 market during the forecast period 2025 - 2030?

The expected CAGR for the Next-Generation Antibody Therapeutics Market Report 2026 market during the forecast period 2025–2030 is 10.9%. request a sample here

What are the key factors driving the Next-Generation Antibody Therapeutics Market Report 2026 market?

Major growth driver of the market includes: Next-Generation Antibody Therapeutics Is A Vital Solution In Addressing The Surge Of Chronic Diseases in the Next-Generation Antibody Therapeutics Market Report 2026 market. For further insights on this market, request a sample here

Which end-use segment are covered in the Next-Generation Antibody Therapeutics Market Report 2026 market report?

The next-generation antibody therapeutics market covered in this report is segmented –
1) By Types Of Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Bispecific Antibodies, Antibody-Drug Conjugates, Other Types
2) By Therapeutic Area: Oncology, Autoimmune Diseases, Infectious Diseases, Neurodegenerative Disorders, Other Therapeutic Areas
3) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users Subsegments:
1) By Monoclonal Antibodies: IgG Monoclonal Antibodies, IgM Monoclonal Antibodies
2) By Polyclonal Antibodies: Serum-Derived Polyclonal Antibodies, Hybridoma-Derived Polyclonal Antibodies
3) By Bispecific Antibodies: Dual-Targeting Antibodies, Single-Chain Variable Fragment (scFv) Antibodies
4) By Antibody-Drug Conjugates (ADCs): Targeted ADCs, Payload Types
5) By Other Types: Nanobodies, Engineered Antibodies request a sample here

What is the anticipated growth trend for the Next-Generation Antibody Therapeutics Market Report 2026 market?

Major trend in this market includes: Revolutionizing Antibody Therapeutics By Exploring Cutting-Edge Technologies And Breakthroughs In Next-Generation Solutions For further insights on this market, request a sample here.

Who are the key players in the Next-Generation Antibody Therapeutics Market Report 2026 market?

Major companies operating in the Next-Generation Antibody Therapeutics Market Report 2026 market are Major companies operating in the next-generation antibody therapeutics market are Pfizer Inc., F. Hoffmann‑La Roche Ltd., Bristol‑Myers Squibb Company, AstraZeneca plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Genentech Inc., Kyowa Hakko Kirin Co. Ltd., Seagen Inc., Seattle Genetics Inc., Xencor Inc., ImmunoGen Inc., Genmab A/S, Zymeworks Inc., NBE‑Therapeutics AG, Daiichi Sankyo Company Limited, Merck & Co Inc., Novartis AG, AbCellera Biologics Inc., Sotio Biotech, F‑Star Therapeutics Ltd., ADC Therapeutics SA, Harbour BioMed request a sample here.

Which region has the most growth potential in the Next-Generation Antibody Therapeutics Market Report 2026 market?

North America was the largest region in the next-generation antibody therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next-generation antibody therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.